Page last updated: 2024-10-23

bumetanide and Arthritis, Rheumatoid

bumetanide has been researched along with Arthritis, Rheumatoid in 1 studies

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research Excerpts

ExcerptRelevanceReference
"Since free radicals are implicated in rheumatoid arthritis (RA) and since uric acid is a free radical scavenger, we examined the effects of treating RA patients with with the diuretic bumetanide to try to improve their arthritic control."5.11Purine modulation of cytokine release during diuretic therapy of rheumatoid arthritis. ( Darlington, LG; Forrest, CM; Harman, G; McMillan, RB; Rana, C; Shaw, S; Stone, TW; Stoy, N, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forrest, CM1
Harman, G1
McMillan, RB1
Rana, C1
Shaw, S1
Stone, TW1
Stoy, N1
Darlington, LG1

Trials

1 trial available for bumetanide and Arthritis, Rheumatoid

ArticleYear
Purine modulation of cytokine release during diuretic therapy of rheumatoid arthritis.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Adenosine-5'-(N-ethylcarboxamide); Adolescent; Adult; Aged; Antineoplastic Agents; Antioxidants; Art

2004